Company Name

Industry

Location

Revenue

Employees

Adams Clinical

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Scipher Medicine

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Mustang Bio

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Dyno Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Silk Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Fulcrum Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

VBI Vaccines

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Xilio Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Cullinan Oncology

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Lyra Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

PROMETRIKA

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

PureTech Health

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Veritas Genetics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Exosome Diagnostics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Invaio

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Arbor Biotechnologies

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Harbor Clinical

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Novoheart

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Disc Medicine

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

KalVista Pharmaceuticals

Biotechnology

United States, Massachusetts

$10M to $25M

51-200